| 臺大學術典藏 |
2021-02-02T08:29:56Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; BOR-RU LIN; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:22:37Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Yeong-Shiau Pu;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; YEONG-SHIAU PU; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:15:04Z |
Antibodies to Epstein?Barr virus?specific DNase in patients with nasopharyngeal carcinoma and control groups
|
Hu C.?P.; Yang C.?S.; CHANG-YAO HSIEH; Lai M.?Y.; Kuo S.?L.; Chen J.?Y.;Chen C.?J.;Liu M.?Y.;Cho S.?M.;Hsu M.?M.;Lynn T.?C.;Shieh T.;Tu S.?M.;Lee H.?H.;Kuo S.?L.;Lai M.?Y.;Chang-Yao Hsieh;Hu C.?P.;Yang C.?S.; Chen J.?Y.; Chen C.?J.; Liu M.?Y.; Cho S.?M.; Hsu M.?M.; Lynn T.?C.; Shieh T.; Tu S.?M.; Lee H.?H. |
| 臺大學術典藏 |
2020-11-27T08:14:40Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Pu Y.-S.;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Chang-Yao Hsieh; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2020-11-03T15:39:36Z |
Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: Effects of covariates on risk
|
Chen P.-R; Yang C.-S; Hildesheim A; Diehl S.R; Chen C.-J.; Hsu M.-M; Lou P.-J; CHENG-PING WANG; Hong J.-H; Leu Y.-S; Tsai M.-H; Su M.-C; Tsai S.-T; Chao W.-Y; Ger L.-P; Chou S.-P; You S.-L; Chen J.-Y; Liu M.-Y; Cheng Y.-J; Chiang C.-J; Chien Y.-C; Yu K.J; Hsu W.-L |
| 臺大學術典藏 |
2020-11-02T02:05:31Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Hsieh C.-Y.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Ho Y.-F.; Hsu M.-M.; Lin J.-K.; Hsu C.-H.; Chen A.-L. |
| 臺大學術典藏 |
2020-10-27T12:04:52Z |
Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma
|
Ko J.-Y; Lui L.T; Sheen T.-S; PEI-JEN LOU; Hsu M.-M. |
| 臺大學術典藏 |
2020-10-27T12:04:49Z |
Intracranial relapse of nasopharyngeal carcinoma manifested as sudden deafness
|
Hsu M.-M.; PEI-JEN LOU; Lin C.-Y; Young Y.-H; Young Y.-H;Lin C.-Y;Pei-Jen Lou;Hsu M.-M. |
| 臺大學術典藏 |
2020-10-27T12:04:19Z |
Partial least square discriminant analysis discovered a dietary pattern inversely associated with nasopharyngeal carcinoma risk
|
PEI-JEN LOU; Chen I.-H; Hildesheim A; Chen C.-J.; Hsu M.-M; Chen J.-Y; Chien Y.-C; Lo Y.-L; Pan W.-H; Hsu W.-L |
